2nd COVID-19 vaccine by Moderna set for FDA approval in US after panel endorsement
By MATTHEW PERRONE and LAURAN NEERGAARD
Published article
In this photo illustration a medical syringe and a vial depicting fake coronavirus vaccine seen in front of the Moderna US biotechnology company logo. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)
WASHINGTON - A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
FDA Advisers Vote To Recommend Moderna For Emergency COVID-19 Vaccine
The Food and Drug Administration is expected to follow the panel s recommendation and approve the second coronavirus vaccine.
Matthew Perrone and Lauran Neergaard
WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
An advisory committee to the U.S. Food and Drug Administration has given a thumbs up to the nation s second COVID-19 vaccine.
The independent Vaccines and Related Biological Products Advisory Committee voted 20-0 with one abstention to support mRNA-1273, a vaccine made in collaboration with the U.S. government by Moderna, a decade-old Cambridge, Massachusetts-based biotechnology company. There s no doubt in my mind – it looks like the benefits outweigh the risks from what I ve seen, said Dr. Steven Pergam, a committee member and infectious disease and vaccine expert at the Fred Hutchinson Cancer Research Center in Seattle, expressing the group s consensus.
AP
TribLIVE s Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox.
WASHINGTON A government advisory panel endorsed a second covid-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The Food and Drug Administration is expected to follow the recommendation for the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up.
The FDA’s green light for emergency use is expected quickly. Moderna would then begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.
Arizona COVID-19 updates: Makeshift morgue set up at Banner hospital in central Phoenix Arizona Republic
A nurse in New York City was among the first people in the United States to receive the first dose of the Pfizer-BioNTech COVID-19 vaccine on Monday morning. Shipments were arriving across the country, with the first boxes arriving in Arizona.
Pima County Health Department director tests positive for COVID-19
Arizona reports 4,848 new COVID-19 cases, 108 deaths
Governor expected to tour Phoenix vaccine site
White Mountain Apache Tribe chairwoman among first to receive vaccine
FDA authorizes nation s first at-home, over-the-counter COVID-19 test
CVS will play key role in COVID-19 vaccine rollout